Elevated levels of AGR2 expression have earlier also been linked to unfavorable tumor features in breast cancer [12], prostate cancer [23], head and neck squamous cell carcinoma [45], and squamous cell carcinoma of the esophagus [29]. Here, AGR2 is linked to prostate cancer.